Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19

DSMB Has Reviewed Interim Clinical and Safety Data and Recommended that the Study Continue DSMB Has Reviewed Interim Clinical and Safety Data and Recommended that the Study Continue

Wed, 01 Jun 2022 05:59 PM (IST)
 0
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
DSMB Has Reviewed Interim Clinical and Safety Data and Recommended that the Study Continue
DSMB Has Reviewed Interim Clinical and Safety Data and Recommended that the Study Continue
Sangri Today Sangri Today is a Weekly Bilingual Newspaper and website of news and current affairs that publishes news reports from various places, from general reports.